Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 575 of 1,261
  1. US 9925182

    Compositions, dosage forms, and co-administration of an opioid agonist compound and an analgesic compound

    Nektar Therapeutics · Granted Mar 27, 2018 · Expires Mar 22, 2038

    granted
  2. US 9925180

    Compounds and anti-tumor NQO1 substrates

    The Board of Regents of the University of Texas System · Granted Mar 27, 2018 · Expires Mar 22, 2038

    granted
  3. US 9925156

    Enterically coated cysteamine, cystamine and derivatives thereof

    The Regents of the University of California · Granted Mar 27, 2018 · Expires Mar 22, 2038

    granted
  4. US 9925209

    Heparosan-polypeptide and heparosan-polynucleotide drug conjugates and methods of making and using same

    The Board of Regents of the University of Oklahoma · Granted Mar 27, 2018 · Expires Mar 22, 2038

    granted
  5. US 9926557

    Methods and means for efficient skipping of exon 45 in Duchenne muscular dystrophy pre-mRNA

    BIOMARIN TECHNOLOGIES B.V. · Granted Mar 27, 2018 · Expires Mar 22, 2038

    granted
  6. US 9926369

    Methods for treating hepatocellular cancer by administering an anti-Ang-2 antibody

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 27, 2018 · Expires Mar 22, 2038

    granted
  7. US 9926372

    Methods and compositions for modulation of blood-neural barrier

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 27, 2018 · Expires Mar 22, 2038

    granted
  8. US 9926324

    Heteroaromatic compounds as PI3 kinase modulators and methods of use

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Mar 27, 2018 · Expires Mar 22, 2038

    granted
  9. US 9925269

    Phospholipid ether analogs as cancer-targeting drug vehicles

    CELLECTAR BIOSCIENCES, INC. · Granted Mar 27, 2018 · Expires Mar 22, 2038

    granted
  10. US 9925271

    Targeted pharmacological chaperones

    Marker Gene Technologies, Inc · Granted Mar 27, 2018 · Expires Mar 22, 2038

    granted
  11. US 9926602

    Recurrent gene fusions in prostate cancer

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 27, 2018 · Expires Mar 22, 2038

    granted
  12. US 9925270

    bFGF-polymer conjugates, methods for making the same and applications thereof

    The Regents of the University of California · Granted Mar 27, 2018 · Expires Mar 22, 2038

    granted
  13. US 9925237

    Polypeptide-polymer conjugates and methods of use thereof

    The Regents of the University of California · Granted Mar 27, 2018 · Expires Mar 22, 2038

    granted
  14. US 9925223

    Methods for making and using antimicrobial peptides

    Regents of the University of Minnesota · Granted Mar 27, 2018 · Expires Mar 22, 2038

    granted
  15. US 9925213

    Nylon-3 co-polymers and synthetic lung surfactant compositions containing same

    Northwestern University · Granted Mar 27, 2018 · Expires Mar 22, 2038

    granted
  16. US 9925188

    DNA-PK inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Mar 27, 2018 · Expires Mar 22, 2038

    granted
  17. US 9925181

    Biopolymer drug loading method

    SOUTH DAKOTA BOARD OF REGENTS · Granted Mar 27, 2018 · Expires Mar 22, 2038

    granted
  18. US 9925157

    Enterically coated cysteamine, cystamine and derivatives thereof

    The Regents of the University of California · Granted Mar 27, 2018 · Expires Mar 22, 2038

    granted
  19. US 9925158

    Enterically coated cysteamine, cystamine and derivatives thereof

    The Regents of the University of California · Granted Mar 27, 2018 · Expires Mar 22, 2038

    granted
  20. US 9925172

    Compounds and methods for treating an epileptic disorder

    The Regents of the University of California · Granted Mar 27, 2018 · Expires Mar 22, 2038

    granted
  21. US 9925162

    Methods and compositions for inducing physiological hypertrophy

    The Regents of the University of Colorado · Granted Mar 27, 2018 · Expires Mar 22, 2038

    granted
  22. US 9920311

    PEGylated L-asparaginase

    Jazz Pharmaceuticals II SAS · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted
  23. US 9920297

    Salmonella-based vectors for cancer immunotherapy targeting wilms' tumor gene WT1

    Vaximm AG · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted
  24. US 9920296

    Paenibacillus alvei strain TS-15 and its use in controlling pathogenic organisms on crops

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVIC · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.